Figure 1From: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762] YBOCS change for treatment groups Quetiapine and placebo groups improved significantly, without significant between group differences (F = 0.19; p = 0.636)Back to article page